H

Hunter Diabetes Centre | Merewether, Australia

Research site
(Unclaimed)
Location
Level 1, 41 Llewellyn Street, Merewether, New South Wales, Australia
Site insights

Top conditions

Diabetes Mellitus (5 trials)

Type 2 Diabetes Mellitus (4 trials)

Obesity (3 trials)

Overweight (3 trials)

COVID-19 (3 trials)

Top treatments

BI 456906
Metformin
Sugar
Semaglutide
Cagrilintide
Tirzepatide
Fenofibrate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 11
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Locations recently updated
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigatio...

Enrolling
Type 2 Diabetes
Drug: Tirzepatide
Drug: Cagrilintide

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Enrolling
Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Semaglutide

The purpose of Part A of this study is to assess the immune response and safety of a booster dose of investigational COVID-19 mRNA vaccines in health...

Active, not recruiting
SARS-CoV-2
Biological: CV0801 Monovalent
Biological: CV0701 Bivalent High dose

The main purpose of this study is to evaluate the efficacy of mRNA 1647 vaccine in CMV-seronegative female participants and to evaluate the safety an...

Active, not recruiting
Cytomegalovirus Infection
Biological: mRNA-1647
Biological: Placebo

This is a randomized, observer-blinded, Phase 2 study evaluating the safety and immunogenicity of a severe acute respiratory syndrome coronavirus 2 (...

Active, not recruiting
COVID-19
Influenza
Drug: Influenza Vaccine
Drug: SARS-CoV-2 rS Vaccine

This study is open to adults who are at least 18 years old and have a body mass index of 27 kg/m² or more. People can take part if they have type 2 d...

Enrolling
Obesity
Diabetes Mellitus, Type 2
Drug: Survodutide
Drug: Placebo

This study is open to adults who are at least 18 years old and havea body mass index (BMI) of 30 kg/m² or more, ora BMI of 27 kg/m² or more and at le...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

The purpose of this study is to evaluate the potential benefits of 145 mg of daily fenofibrate in adults with type 1 diabetes mellitus and pre-existi...

Enrolling
Diabetic Nephropathies
Type 1 Diabetes Mellitus
Drug: Inert lactose placebo
Drug: Fenofibrate

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems